

Please try another search
Investing.com - Novocure Ltd (NASDAQ: NVCR) reported first quarter EPS of $-0.50, $0.18 worse than the analyst estimate of $-0.32. Revenue for the quarter came in at $122.2M versus the consensus...
Investing.com - Novocure Ltd (NASDAQ: NVCR) reported fourth quarter EPS of $-0.36, $0.06 worse than the analyst estimate of $-0.30. Revenue for the quarter came in at $128.43M versus the consensus...
Novocure (NVCR) reported Q4 EPS of ($0.36), $0.06 worse than the analyst estimate of ($0.30). Revenue for the quarter came in at $128.43 million versus the consensus estimate of $129.27 million.
Novocure (NVCR) reported Q3 EPS of ($0.25), $0.01 better than the analyst estimate of ($0.26). Revenue for the quarter came in at $130.99 million versus the consensus estimate of $132.42 million.
Investing.com - Novocure Ltd reported on Thursday third quarter earnings that beat analysts' forecasts and revenue that fell short of expectations. Novocure Ltd announced earnings per share of...
Novocure (NVCR) reported Q2 EPS of ($0.23), $0.08 worse than the analyst estimate of ($0.15). Revenue for the quarter came in at $140.9 million versus the consensus estimate of $135.33 million.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review